Page last updated: 2024-08-24

triazoles and Carcinoma, Lewis Lung

triazoles has been researched along with Carcinoma, Lewis Lung in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (28.57)18.2507
2000's1 (14.29)29.6817
2010's4 (57.14)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, C; Chen, W; Guo, L; Ju, R; Li, J; Shi, J; Sun, F; Ye, C; Zhang, D; Zhu, L1
Lee, D; Lee, HE; Lee, SH; Lee, T; Lee, YM; Park, K1
Chen, C; Chen, W; Guo, L; Ju, R; Li, J; Ye, CY; Zhang, DC; Zhu, L1
Barnett, J; Cuthbertson, A; Morrison, MS; Ricketts, SA; Tessier, J; Wedge, SR1
Guo, L; Ju, R; Li, J; Wu, D; Ye, C; Zhang, D1
Diatchkovskaya, RF; Kagiya, TV; Konovalova, NP; Volkova, LM1
Ara, G; Chen, YN; Holden, SA; Korbut, TT; Northey, D; Teicher, BA1

Other Studies

7 other study(ies) available for triazoles and Carcinoma, Lewis Lung

ArticleYear
Carboxyamidotriazole Synergizes with Sorafenib to Combat Non-Small Cell Lung Cancer through Inhibition of NANOG and Aggravation of Apoptosis.
    The Journal of pharmacology and experimental therapeutics, 2017, Volume: 362, Issue:2

    Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carcinoma, Lewis Lung; Carcinoma, Non-Small-Cell Lung; Dose-Response Relationship, Drug; Drug Synergism; Lung Neoplasms; Male; Mice; Mice, Inbred C57BL; Nanog Homeobox Protein; Niacinamide; Phenylurea Compounds; Sorafenib; Triazoles; Xenograft Model Antitumor Assays

2017
Molecular and functional evaluation of a novel HIF inhibitor, benzopyranyl 1,2,3-triazole compound.
    Oncotarget, 2017, Jan-31, Volume: 8, Issue:5

    Topics: A549 Cells; Angiogenesis Inhibitors; Animals; Carcinoma, Lewis Lung; Chick Embryo; Chorioallantoic Membrane; Dose-Response Relationship, Drug; Gene Expression Regulation, Neoplastic; HEK293 Cells; Human Umbilical Vein Endothelial Cells; Humans; Hydroxylation; Hypoxia-Inducible Factor 1, alpha Subunit; Lung Neoplasms; Mice, Inbred C57BL; Neovascularization, Physiologic; Protein Stability; Proteolysis; Response Elements; Signal Transduction; Time Factors; Transfection; Triazoles; Tumor Burden; Tumor Hypoxia; Tumor Microenvironment; Ubiquitination; Vascular Endothelial Growth Factor A

2017
Carboxyamidotriazole alleviates muscle atrophy in tumor-bearing mice by inhibiting NF-κB and activating SIRT1.
    Naunyn-Schmiedeberg's archives of pharmacology, 2017, Volume: 390, Issue:4

    Topics: Adipose Tissue; Animals; Antineoplastic Agents; Cachexia; Carcinoma, Lewis Lung; Interleukin-6; Male; Mice, Inbred C57BL; Muscle, Skeletal; Muscular Atrophy; NF-kappa B; Sirtuin 1; Triazoles; Tumor Burden; Tumor Necrosis Factor-alpha

2017
Use of a novel Arg-Gly-Asp radioligand, 18F-AH111585, to determine changes in tumor vascularity after antitumor therapy.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2009, Volume: 50, Issue:1

    Topics: Animals; Antineoplastic Agents; Carcinoma, Lewis Lung; Carcinoma, Non-Small-Cell Lung; Dose-Response Relationship, Drug; Mice; Neoplasms; Oligopeptides; Paclitaxel; Peptides; Polyethylene Glycols; Positron-Emission Tomography; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Quinazolines; Receptors, Vascular Endothelial Growth Factor; Tissue Distribution; Triazoles

2009
Inhibition of pro-inflammatory cytokines in tumour associated macrophages is a potential anti-cancer mechanism of carboxyamidotriazole.
    European journal of cancer (Oxford, England : 1990), 2012, Volume: 48, Issue:7

    Topics: Animals; Anti-Inflammatory Agents; Antineoplastic Combined Chemotherapy Protocols; Arthritis, Experimental; Carcinoma, Lewis Lung; Coculture Techniques; Cytokines; Dexamethasone; Macrophages; Macrophages, Peritoneal; Male; Mice; Mice, Inbred C57BL; Neoplasm Transplantation; Neoplasms; Rats, Wistar; Triazoles; Tumor Microenvironment; Tumor Necrosis Factor-alpha

2012
Radiosensitizer AK-2123 as modulating agent in the chemotherapy of experimental metastases.
    Neoplasma, 1995, Volume: 42, Issue:3

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Lewis Lung; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Synergism; Female; Melanoma, Experimental; Mice; Mice, Inbred Strains; Neoplasm Transplantation; Radiation-Sensitizing Agents; Triazoles

1995
CAI: effects on cytotoxic therapies in vitro and in vivo.
    Cancer chemotherapy and pharmacology, 1994, Volume: 34, Issue:6

    Topics: Aminoimidazole Carboxamide; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Lewis Lung; Carmustine; Cisplatin; Cyclophosphamide; Fibrosarcoma; Mammary Neoplasms, Experimental; Melphalan; Mice; Triazoles; Tumor Cells, Cultured

1994